Scores on the Three-Factor Eating Questionnaire (TFEQ-R18) improved in all treatment groups, with Cagrilintide producing greater improvements than placebo in specific domains: cognitive restraint, notably at 1.2 mg and 4.5 mg, emotional eating notably at 0.3 mg and 2.4 mg, and uncontrolled eating notably at 1.24.5 mg
A cGMP certification ensures that the manufacturing facility is meeting FDA guidelines, while third-party testing is a service that brands can pay for to provide more transparency to their customers
EGCG-treated rat liver showed a decrease The MDA levels was significantly decrease, while GSH and SOD levels was clearly elevated in mice treated with EGCG (83), the antioxidant activity of the liver increased
this process reduces mitophagy activation levels, leading to increased mitochondrial membrane potential, cytochrome c release, and activation of caspase-3 and caspase-9, ultimately causing widespread apoptosis and liver injury [42]